Livzon Group (Ningxia) Pharmaceutical Co., Ltd.

Form 483FOIA Uncovered

Shizuishan, -FEI 3012375554Issued October 19, 2018

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3012375554.

ObservationsNot available

Issue DateOctober 19, 2018

StatusNo Warning Letter

Related Inspections4

Establishment Details

Firm: Livzon Group (Ningxia) Pharmaceutical Co., Ltd.
Location: Shizuishan, -
FEI Number: 3012375554
Product Type: Drugs
Issue Date: October 19, 2018
Country: United States

Inspection History, 2017 to 2025

NAI1

VAI2

OAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Livzon Group (Ningxia) Pharmaceutical Co., Ltd. FDA Form 483, Shizuishan, October 19, 2018